| Product NDC: | 0555-0808 |
| Proprietary Name: | Tretinoin |
| Non Proprietary Name: | Tretinoin |
| Active Ingredient(s): | 10 mg/1 & nbsp; Tretinoin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0555-0808 |
| Labeler Name: | Barr Laboratories Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077684 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20070626 |
| Package NDC: | 0555-0808-02 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (0555-0808-02) |
| NDC Code | 0555-0808-02 |
| Proprietary Name | Tretinoin |
| Package Description | 100 CAPSULE in 1 BOTTLE (0555-0808-02) |
| Product NDC | 0555-0808 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Tretinoin |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20070626 |
| Marketing Category Name | ANDA |
| Labeler Name | Barr Laboratories Inc. |
| Substance Name | TRETINOIN |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Retinoid [EPC],Retinoids [Chemical/Ingredient] |